Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
In Vitro Diagnostic Packaging Market Growth Potential: How Will Market Size Shift Through 2030?
The in vitro diagnostic packaging market has witnessed robust growth over recent years. This market is anticipated to expand, moving from $10.04 billion in 2025 to $10.82 billion in 2026, with a compound annual growth rate (CAGR) of 7.8%. Historically, this growth can be ascribed to several factors, including the increasing uptake of in vitro diagnostic testing, the expansion of clinical laboratory infrastructure, a rising demand for precise disease diagnosis, an increase in global healthcare expenditure, and the advent of advanced packaging materials.
The in vitro diagnostic packaging market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $14.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. The anticipated expansion during this period stems from factors such as the increasing prevalence of point-of-care diagnostics, a heightened emphasis on environmentally friendly medical packaging, the broadened scope of molecular diagnostics testing, increased financial commitments to healthcare infrastructure, and a stronger focus on the security and reliability of the supply chain. Key developments expected within the forecast timeframe involve a heightened need for sterile and contamination-proof packaging, the growing embrace of tamper-evident IVD packaging options, expanded utilization of high-barrier plastic and glass substances, the proliferation of tailored packaging for diagnostic kits, and a more pronounced emphasis on packaging designs that adhere to regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
In Vitro Diagnostic Packaging Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The future expansion of the in vitro diagnostic (IVD) packaging market is anticipated to be driven by an increase in the occurrence and spread of chronic diseases and infections. These conditions are defined as persistent health issues or illnesses resulting from pathogens, which endure over time and frequently result in lasting medical problems. This surge in their incidence and prevalence stems from heightened exposure to pathogens, with lifestyle decisions, especially inadequate nutrition and insufficient exercise, playing a crucial role. IVD packaging plays a vital role in tackling chronic diseases and infections by guaranteeing the secure, dependable, and effective transport of diagnostic tests. This facilitates early discovery and prompt intervention, consequently enhancing patient health results and overall healthcare effectiveness. For example, data released in March 2025 by the UK Health Security Agency, an executive body in the UK, indicated that in England, the UK Health Security Agency (UKHSA) documented 368 measles cases in 2023. This represents an almost sevenfold rise compared to the 53 cases recorded in 2022, with the West Midlands contributing 44% and London 33% of these cases. Consequently, the expanding incidence and prevalence of chronic diseases and infections are propelling the in vitro diagnostic packaging market.
In Vitro Diagnostic Packaging Market Segment Analysis Spotlighting Growth Areas
The in vitro diagnostic packaging market covered in this report is segmented –
1) By Packaging Type: Primary Packaging, Secondary Packaging, Tertiary Packaging
2) By Product: Bottles And Vials, Tubes, Petri Dishes, Closures, Other Products
3) By Material Type: Plastic, Glass, Metal, Composite Materials
4) By Application Area: Biochemistry, Microbiology, Immunology, Molecular Diagnostics
5) By End User: Hospitals, Laboratories, Academic Institutes, Other End Users
Subsegments:
1) By Primary Packaging: Cartridges, Microplates, Sample Collection Containers, Reagent Reservoirs, Diagnostic Cassettes, Dropper Bottles
2) By Secondary Packaging: Folding Cartons, Paperboard Sleeves, Trays, Multi-Compartment Boxes, Label Sets, Instruction Leaflets
3) By Tertiary Packaging: Corrugated Shipping Boxes, Pallets, Insulated Shippers, Foam Inserts Or Cushioning, Tamper-Evident Seals, Bulk Transport Containers
In Vitro Diagnostic Packaging Market Innovation Trends Shaping Future Development
Major companies in the in vitro diagnostic packaging market are concentrating on developing innovative products, specifically sustainable IVD packaging solutions, to improve sustainability and decrease the environmental impact of diagnostic product packaging. A sustainable IVD (in vitro diagnostic) packaging solution is defined by the use of eco-friendly materials and practices in diagnostic product packaging, aiming to reduce environmental impact while preserving product safety and integrity. For instance, in March 2025, Oxford Gene Technology IP Limited, a UK-based provider of diagnostic genomic solutions, introduced an environmentally sustainable packaging solution for its CytoCell product line. This advanced packaging employs biodegradable and recyclable materials, reflecting the industry’s increasing move towards eco-friendly practices. The redesigned packaging not only supports a more sustainable approach to product disposal but also simplifies processes for laboratories through streamlined and easily accessible digital documentation. This action reaffirms the company’s commitment to waste reduction and improved operational efficiency in both the clinical and diagnostic sectors.
In Vitro Diagnostic Packaging Market Company Landscape And Competitive Strategy
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation
View The Full In Vitro Diagnostic Packaging Market Report:
In Vitro Diagnostic Packaging Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
